Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Ozempic and its counterparts, including Wegovy, Mounjaro and Zepbound, have surged in popularity as a means for weight loss, fueled by celebrity endorsements and slick pharmaceutical marketing.

Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

People with diabetes who used semaglutide or other GLP-1 agonists were also less likely to see a provider for depression.

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...